Search - tctmd.com

Displaying 121 - 140 of 299

Sort: Relevancy | Date

Presentation NY Valves 2025

Reviewing the Main Clinical Findings From Recent TTVI Clinical Trials

Presenter: Charles J. Davidson

June 26, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

Presentation NY Valves 2025

Expanding Clinical Indications and Future Trials

Presenter: Martin B. Leon

June 25, 2025

Presentation NY Valves 2025

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Presenter: Yasser M. Sammour

June 25, 2025

Presentation NY Valves 2025

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

Presenter: Santiago Garcia

June 25, 2025

Presentation NY Valves 2025

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Presenter: Shinichi Fukuhara

June 25, 2025

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Clinical Trials Update: Real-World Tricuspid TEER Registries

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

Greater Frailty Means More Complications, Higher Mortality After PCI

Todd Neale

June 16, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

Podcast Rox Heart Radio

A Vision for Clinical Trials

June 11, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Michael O'Riordan

June 10, 2025

News Daily News

Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures

Todd Neale

June 10, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

Advertisement

Reviewing the Main Clinical Findings From Recent TTVI Clinical Trials

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Expanding Clinical Indications and Future Trials

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Clinical Trials Update: Real-World Tricuspid TEER Registries

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Amylin Analogue Boosts Weight Loss When Added to GLP-1

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Greater Frailty Means More Complications, Higher Mortality After PCI

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

A Vision for Clinical Trials

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content